Cargando…
A New Approach for Loading Anticancer Drugs Into Mesenchymal Stem Cell-Derived Exosome Mimetics for Cancer Therapy
Exosomes derived from mesenchymal stem cells (MSCs) have been evaluated for their potential to be used as drug delivery vehicles. Synthetically personalized exosome mimetics (EMs) could be the alternative vesicles for drug delivery. In this study, we aimed to isolate EMs from human MSCs. Cells were...
Autores principales: | Kalimuthu, Senthilkumar, Gangadaran, Prakash, Rajendran, Ramya Lakshmi, Zhu, Liya, Oh, Ji Min, Lee, Ho Won, Gopal, Arunnehru, Baek, Se Hwan, Jeong, Shin Young, Lee, Sang-Woo, Lee, Jaetae, Ahn, Byeong-Cheol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168623/ https://www.ncbi.nlm.nih.gov/pubmed/30319428 http://dx.doi.org/10.3389/fphar.2018.01116 |
Ejemplares similares
-
In vivo Non-invasive Imaging of Radio-Labeled Exosome-Mimetics Derived From Red Blood Cells in Mice
por: Gangadaran, Prakash, et al.
Publicado: (2018) -
Migration of mesenchymal stem cells to tumor xenograft models and in vitro drug delivery by doxorubicin
por: Kalimuthu, Senthilkumar, et al.
Publicado: (2018) -
Targeting and Therapy of Glioblastoma in a Mouse Model Using Exosomes Derived From Natural Killer Cells
por: Zhu, Liya, et al.
Publicado: (2018) -
Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma
por: Zhu, Liya, et al.
Publicado: (2017) -
Reverting iodine avidity of radioactive-iodine refractory thyroid cancer with a new tyrosine kinase inhibitor (K905-0266) excavated by high-throughput NIS (sodium iodide symporter) enhancer screening platform using dual reporter gene system
por: Oh, Ji Min, et al.
Publicado: (2018)